medigraphic.com
ISSN 0188-2198 (Print)

2012, Number 2

<< Back Next >>

Rev Mex Cardiol 2012; 23 (2)

Prevalence of cardiac events in patients stratified by dobutamine stress echocardiogram

Guzmán-Sánchez CM, Castán-Flores DA, Martínez-Macedo G

Language: Spanish
References: 27
Page: 52-57
PDF size: 77.03 Kb.


ABSTRACT

Introduction: The dobutamine stress echocardiogram is a widely used tool for risk stratification in patients experiencing an acute coronary event. Purpose: To describe the prevalence of sudden death, acute myocardial infarction with ST-elevation, acute myocardial infarction without ST elevation and unstable angina in patients stratified by ESD in our hospital during 2007, in a follow-up period of two years. Material and methods: Cross-sectional study, analytical, descriptive, using as units of observation records dobutamine stress echocardiography in patients evaluated in the Western National Medical Center in 2007. Results: We analyzed 142 records of ESD, 79 positive studies. Patients with positive ESD were divided according to the affected segments, the prevalence in patients with 1 to 2 segments affected was 42%, with 0% mortality, the prevalence in patients with 3 to 4 segments affected was 32.25%, with 0 % mortality, in patients with 5 or more affected segments revascularized was 0% versus 14.3% in the same group of patients who were not revascularized. Conclusions: The results is not different than expected, but we believe that patients with positive ESD at low and intermediate risk are less closely monitored, and high-risk patients have fewer prevalence as they are rapidly revascularized.


REFERENCES

  1. Minardi G, Manzara C, Pino PG. Feasibility, safety and tolerability of accelerated dobutamine stress echocardiography. Cardiovasc Ultrasound 2007; 5: 40.

  2. Picano E. Stress echocardiography. Expert Rev Cardiovasc Ther 2004; 2: 77-88.

  3. Amstrong WF, Ryan T. Stress echocardiography from 1979 to present. J Am Soc Echocardiogr 2008; 21: 22-28.

  4. Douglas PS, Khandheria B, Stainback RF et al. ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography. Circulation 2008; 117: 1478-1497.

  5. Heijenbrok-Kal MH, Fleischmann KE, Hunink MG. Stress echocardiography, stress single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease: a meta-analysis of diagnostic performance. Am Heart J 2007; 154: 415-423.

  6. Pratali L, Molinaro S. Prognostic value of pharmacologic stress echocardiography in patients with idiopathic dilated cardiomyopathy: a prospective, head-to-head comparison between dipyridamole and dobutamine test. J Card Fail 2007; 13: 836-842.

  7. Jeetley P, Burden L. Clinical and economic impact of stress echocardiography compared with exercise electrocardiography in patients with suspected acute coronary syndrome but negative troponin: a prospective randomized controlled study. Eur Heart J 2007; 28: 204-211.

  8. Anthony D. Diagnosis and screening of coronary artery disease. Prim Care 2005; 32: 931-946.

  9. Gottdiener JS. Overview of stress echocardiography: uses, advantages, and limitations. Curr Probl Cardiol 2003; 28: 485-516.

  10. Bax JJ. Prognostic role of dobutamine stress echocardiography in myocardial viability. Curr Opin Cardiol 2006; 21: 443-449.

  11. Sawada SG, Safadi A. Stress-induced wall motion abnormalities with low-dose dobutamine infusion indicate the presence of severe disease and vulnerable myocardium. Echocardiography 2007; 24: 739-744.

  12. Bax JJ, Ferrari R. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol 2007; 32: 375-410.

  13. Varga A, García MA. Safety of stress echocardiography (from the International Stress Echo Complication Registry). Am J Cardiol 2006; 98: 541-543.

  14. Artis NJ. Two-dimensional strain imaging: a new echocardiographic advance with research and clinical applications. Int J Cardiol 2008; 123: 240-248.

  15. Amstrong WF. Stress echocardiography: current methodology and clinical applications. J Am Coll Cardiol 2005; 45: 1739-1747.

  16. Feringa HH, Bax JJ. The long prognostic value of wall motion abnormalities during the recovery phase of dobutamine stress echocardiography after receiving acute beta-blockade. Coron Artery Dis 2007; 18: 187-192.

  17. Picano E. Stress echocardiography. Curr Pharm Des 2005; 11: 2137-2149.

  18. Nemes A, Galema TW. Dobutamine stress echocardiography for the detection of coronary artery disease in women. Am J Cardiol 2007; 99: 714-729.

  19. Biagini D, Bax JJ. The use of stress echocardiography for prognostication in coronary artery disease: an overview. Curr Opin Cardiol 2005; 20: 386-394.

  20. Markman J. Stratifying the risk in unstable angina with dobutamine stress echocardiography. Arq Bras Cardiol 2006; 87: 294-299.

  21. McBride C, Huber T. Clinical inquiries. What is the prognostic value of stress echocardiography for patients with atypical chest pain? J Fam Pract 2006; 55: 902-904.

  22. Pillary T. Detection of myocardial viability by dobutamine stress echocardiography: incremental value of diastolic wall thickness measurement. Heart 2005; 91: 613-617.

  23. Paul B. Dobutamine stress echocardiography--methodology, clinical applications and current perspectives. J Assoc Physicians India 2004; 52: 653-657.

  24. Noguchi Y. A meta-analytic comparison of echocardiographic stressors. Int J Cardiovasc Imaging 2005; 21: 189-207.

  25. Senior R. Stress echocardiography for the diagnosis and risk stratification of patients with suspected or known coronary artery disease: a critical appraisal. Supported by the British Society of Echocardiography. Heart 2005; 91: 427-436.

  26. Pellikka PA. Stress echocardiography for the diagnosis of coronary artery disease: progress towards quantification. Curr Opin Cardiol 2005; 20: 395-398.

  27. Picano E. Stress echocardiography. Minerv Cardioangiol 2005; 53: 195-210.




2020     |     www.medigraphic.com